Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer

BACKGROUND: Many tools have been developed to predict the efficacy of immunotherapy, such as lung immune prognostic index (LIPI), EPSILoN [Eastern Cooperative Oncology Group performance status (ECOG PS), smoking, liver metastases, lactate dehydrogenase (LDH), neutrophil‐to‐lymphocyte ratio (NLR)], a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qian, Li, Butuo, Xu, Yiyue, Wang, Shijiang, Zou, Bing, Yu, Jinming, Wang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446565/
https://www.ncbi.nlm.nih.gov/pubmed/34390218
http://dx.doi.org/10.1002/cam4.4171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446565/
https://www.ncbi.nlm.nih.gov/pubmed/34390218
http://dx.doi.org/10.1002/cam4.4171

Ejemplares similares